14-day Premium Trial Subscription Try For FreeTry Free
Zacks Investment Research downgraded shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zack
Zacks Investment Research upgraded shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a hold rating to a buy rating in a report issued on Monday morning, Zacks.com reports. The brokerage currently h
Concert announced the details of its pivotal Phase 3 trials of CTP-543 in patients with moderate-to-severe alopecia areata.
Gaming and Leisure Properties trading resumes GLPI

Sinclair Broadcast trading resumes SBGI

02:26pm, Monday, 30'th Mar 2020
Sinclair Broadcast trading resumes SBGI

NASDAQ market internals summary $NSD

02:25pm, Monday, 30'th Mar 2020
NASDAQ market internals summary $NSD
MGM Growth Properties participates in a conference call with JPMorgan MGP
Raytheon, Missile Defense Agency sign $2B Standard Missile-3 contract RTN
Cheesecake Factory put volume heavy and directionally bearish CAKE

NYSE market internals summary $NYE

02:25pm, Monday, 30'th Mar 2020
NYSE market internals summary $NYE
Microsoft sees 775% usage jump in cloud services regions with 'shelter in place' MSFT
U.S. pending home sales rose 2.4% to 111.5 in February
Fly Intel: Top five analyst downgrades MMM HLT MAR DBI BWA MDT
Fly Intel: Top five analyst initiations BSGM LLNW ATSG CNCE GFL
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE